Fully biologic endothelialized-tissue-engineered vascular conduits provide antithrombotic function and graft patency

MLA

Park, Jinkyu, et al. “Fully Biologic Endothelialized-Tissue-Engineered Vascular Conduits Provide Antithrombotic Function and Graft Patency.” Cell Stem Cell, vol. 32, no. 1, Jan. 2025, p. 137–143.e6. EBSCOhost, https://doi.org/10.1016/j.stem.2024.11.006.

APA

Park, J., Riaz, M., Qin, L., Zhang, W., Batty, L., Fooladi, S., Kural, M. H., Li, X., Luo, H., Xu, Z., Wang, J., Banno, K., Gu, S. X., Yuan, Y., Anderson, C. W., Ellis, M. W., Zhou, J., Luo, J., Shi, X., … Qyang, Y. (2025). Fully biologic endothelialized-tissue-engineered vascular conduits provide antithrombotic function and graft patency. Cell Stem Cell, 32(1), 137–143.e6. https://doi.org/10.1016/j.stem.2024.11.006

Chicago

Park, Jinkyu, Muhammad Riaz, Lingfeng Qin, Wei Zhang, Luke Batty, Saba Fooladi, Mehmet H. Kural, et al. 2025. “Fully Biologic Endothelialized-Tissue-Engineered Vascular Conduits Provide Antithrombotic Function and Graft Patency.” Cell Stem Cell 32 (1): 137–143.e6. doi:10.1016/j.stem.2024.11.006.